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ABSTRACT: A few new psychoactive substances (NPS) that mimic
the effects of controlled neuropsychiatric and illicit drugs have been
forensically identified in the U.S. Wastewater-based epidemiology
(WBE) can provide a comprehensive and more cost- and time-effective
method of determining the prevalence of NPSs in communities. In this
study, an analytical method capable of simultaneous determination of
trace-level 40 NPS residues (synthetic opioids, synthetic cannabinoids,
synthetic cathinones, piperazines, indole, and amphetamine) in
wastewater was developed and validated. The developed analytical
method was utilized to determine the occurrence of NPSs in four rural
communities in southern Illinois. Nine NPSs (carfentanil, furanyl
fentanyl, methoxyacetyl fentanyl, MAB-CHMINACA, methcathinone,
4-methyl pentedrone, 2-methyl-4′-(methylthio)-2-morpholinopropio-
phenone (MMMP), 1-(3-chlorophenyl) piperazine (mCPP), and 5-(2-
Aminopropyl) Indole (5IT) were quantified. Methcathinone was the most frequently detected NPS (detection frequency, df =
100%) followed closely by the MMMP and mCPP (df = 91%). The mass loading of methcathinone, mCPP, and 5-IT using
ammoniacal nitrogen-based population were up to 21.1 ± 1.3 mg/d/1000 people, 15.0 ± 0.5 mg/d/1000 people, and 9.75 ± 2.72
mg/d/1000 people, respectively. This is the first study to determine the occurrence of NPSs including synthetic opioids, synthetic
cannabinoids, synthetic cathinones, and piperazines in the U.S. communities.
■ INTRODUCTION
New narcotics or psychoactive substances (NPS) in “pure” or
“preparation” forms are created to have the similar effects of
established prescribed and illicit neuropsychiatric drugs.1
There were ∼500 NPS in the global market each year from
2015 to 2017.2 In the U.S., the forensic identifications of NPS
tripled from 684 identifications in 2016 to 2023 identifications
including 1783 opioids/analgesics, 81 synthetic cannabinoids,
55 synthetic cathinones, 46 benzodiazepines, and 58 “others”
in 2019.3 There were five NPS (carfentanil, furanyl fentanyl, 5-
fluoro AMB, 5-fluoro ADB, and Nethylpentylone) among 25
most prevalent drugs in the Midwest in 2017.4 National Drug
Early Warning System (NDEWS) reported 3099 counts of
fentanyl, 670 counts of synthetic cathinones, and 633 counts of
synthetic cannabinoids seizures in 2017 in Illinois by the law
enforcement.5
The NDEWS has reported the prevalence of NPS based on
the forensic analyses, which can underestimate the actual
amount of abused drugs and cause a delay between the
outbreak of a drug and the intervention of law enforcement.
Wastewater-based epidemiology (WBE) provides a non-
invasive, comprehensive, cost-effective, and near-real-time
estimation of the prevalence of substance use in a
community.6−8 WBE has recently been demonstrated as a
complementary tool to a forensic toxicological approach to
comprehend a trend in the consumption of NPS in Australia.9
NPSs are reintroduced in markets in quick succession to
impede the law enforcement’s efforts to control NPS
production and purchases.1 Therefore, the traditional
approaches are not suitable for drug monitoring, surveillance,
control, and the immediate responses to the harm associated
with the NPS.10,11 WBE can be used as a proactive public
health surveillance system for NPS for prompt intervention. In
WBE, the residual parent drugs or their metabolites in raw
wastewater are utilized to back-calculate the prevalence of
target drugs in a community.
NPS typically are more potent and toxic than established
drugs of abuse, such as illicit drugs and prescribed opioids.
Carfentanil, a synthetic opioid, is ∼100 folds more potent than
Received: January 13, 2020
Revised: May 1, 2020
Accepted: May 1, 2020
Published: May 1, 2020
Articlepubs.acs.org/est
© 2020 American Chemical Society
6661
https://dx.doi.org/10.1021/acs.est.0c00250



























































































fentanyl and ∼10 000 folds more powerful than morphine.
Synthetic cannabinoids mimic the psychotropic effects of
cannabis-derived cannabinoids (e.g., Δ9-tetrahydrocannabinol:
THC) binding similarly to the cannabinoid receptors;
however, synthetic cannabinoids are more potent and
efficacious cannabinoid receptors antagonists than THC.12
Similarly, 3,4-methylenedioxypyrovalerone, a common synthetic
cathinone, has similar effects as cocaine but ≥10 folds more
powerful than cocaine.1 Therefore, the potential ultratrace
level of NPS in wastewater, a complex environmental matrix,
poses analytical challenges for the detection and quantification.
NPS in wastewater typically have been enriched using solid-
phase extraction (SPE) and analyzed using a high-performance
liquid chromatography tandem mass spectrometric technique
(HPLC-MS/MS) for target quantification13−15 as well as
Orbitrap high resolution mass spectrometer16,17 and time-of-
flight mass spectrometer18−20 for target and untargeted
screening. The majority of the reports used either neutral
HLB (hydrophilic−lipophilic balance) or mix mode cation-
exchange cartridges (MCX or WCX) for the quantification of
few NPSs of a particular class of drugs, such as synthetic
cannabinoids or synthetic cathinones. Typically, nonacidified
wastewater samples were extracted via the preconditioned
HLB cartridge (with methanol followed by water) and eluted
with methanol;17,21 however, acidified (pH ∼ 2−5) wastewater
samples were extracted via the preconditioned MCX cartridge
(with methanol followed by acidified water) and eluted with
methanol followed by ammoniacal methanol (∼2 or
5%).16,17,22
Bade et al.23 found MCX-extraction more efficient than
HLB-extraction for synthetic cathinones whereas Fontanals et
al.16 preferred WCX over MCX for synthetic cathinones. To
the authors’ knowledge, there was no report of the optimized
extraction of synthetic fentanyls from wastewater. Salguero-
Gonzalez et al.16 used both HLB and MCX cartridges to cover
the wide range of physio-chemical properties of NPSs
including synthetic cathinones and synthetic cannabinoids.
All WBE studies on NPS have focused on synthetic
cannabinoids and synthetic cathinones. To our knowledge,
there are no reports of simultaneous quantification of synthetic
cathinones, synthetic cannabinoids, and synthetic opioids in
wastewater. The prevalence of NPS in communities using
WBE have been reported in Europe11,13,17,24 Australia,9,23 and
China.22 However, this is the first study of reporting NPSs in
wastewater in the U.S.
In this study, an analytical method capable of simultaneous
trace-level determination of 40 NPS residues including 11
synthetic cannabinoids, 10 synthetic cathinones, 15 synthetic
opioids, 2 piperazines, 1 indole, and 1 amphetamine in
wastewater has been developed and validated. The occurrence
of NPS in four rural southern communities in Illinois was
determined based on the level of NPSs measured for seven
consecutive days. Moreover, clonazepam (benzodiazepine,)
and gabapentin (anticonvulsant) were also determined as a
potential chemical marker of NPS prevalence in target
communities owing to the regional potential abuse.25
■ MATERIALS AND METHODS
Reagents and Chemicals. Based on the frequent forensic
identifications of NPS by the NDEWS in the U.S.,3−6 40 NPS
were selected belonging to opioids/analgesics, synthetic
cannabinoids, synthetic cathinones, piperazines, indoles, and
amphetamines. Target drugs include opioids/analgesics:
carfentanil, furanyl fentanyl, valeryl fentanyl, butyryl fentanyl,
acetyl fentanyl, cyclopropyl fentanyl, benzyl fentanyl, 3′-methyl
fentanyl, 4′-methyl acetyl fentanyl, 4-fluoro-isobutyryl fentanyl,
para-fluorobutyryl fentanyl, methoxyacetyl fentanyl, 4-ANPP,
U-48800, U-47700; synthetic cannabinoids: 5-fluoro MDMB-
PICA, MAB-CHMINACA, MMB-FUBINACA, 5-fluoro
EDMB-PINACA, (R)-5-fluoro ADB, AB-FUBINACA, MMB-
CHMICA, AB-CHMINACA, ADB-FUBINACA, 5-fluoro
AMB, NM2201; synthetic cathinones: (±)-methcathinone,
ethylone, 4-MMC/mephedrone (MMC), 4-methyl pente-
drone, N-ethylpentylone, α-pyrrolidinopropiophenone, 3,4-
methylenedioxypyrovalerone, α-ethylaminohexanophenone, 2-
methyl-4′-(methylthio)-2-morpholinopropiophenone, 4-
chloro-α-PVP; piperazines: 1-(3-chlorophenyl) piperazine
(mCPP), 1-cyclohexyl-4-(1,2-diphenylethyl) piperazine (MT-
45); indole: 5-(2-aminopropyl) indole (5IT); amphetamine: 4-
methylamphetamine. Target drugs also include two of the
most commonly used anticonvulsants in the U.S. gabapentin
and clonazepam.
High purity standard solutions (50, 100, or 1000 μg/mL) or
solids (1 or 5 mg) of each target drug and the corresponding
deuterated internal standards (carfentanil-d5, furanyl fentanyl
-d5, valeryl fentanyl-d5, butyryl fentanyl-d5, acetyl fentanyl-
13C6,
cyclopropyl fentanyl-d5, 4-fluoro-isobutyryl fentanyl-d7, 4′-
methyl acetyl fentanyl-d5, methoxyacetyl fentanyl-d5, 4-
ANPP-d5, MAB-CHMINACA-d4, U-48800-d3, U-47700-d3,
AB-FUBINACA-d4, N-ethylpentylone-d5, methcathinone-d3,
ethylone-d5, mephedrone-d3, 3,4-methylenedioxypyrovaler-
one-d8, mCPP-d8, MT45-d11, gabapentin-d10, clonazepam-d4)
were purchased from Cerilliant (Round Rock, TX) or Cayman
Chemical (Ann Arbor, MI) and stored at −20 °C. HPLC grade
methanol and formic acid (99.5% purity) were purchased from
Fisher Scientific (Hampton, NH), hydrochloric acid and
ammonium hydroxide were purchased from Pharmco (Brook-
field, CT), and ultrapure water was prepared with Barnstead
Ultrapure System.
Sample Collection. Samples from four WWTPs in four
rural counties in Southern Illinois (C1, C2, C3, and C4) were
collected for seven consecutive days during a typical week with
no special events (to the best of our knowledge) in early
August of 2019. An aliquot of untreated wastewater was
withdrawn every 15 min using a time-proportional autosampler
for 24 h, composited, and stored at 4 °C. However, grab
samples were collected from C4 around noon due to the
unavailability of an autosampler. The week-average wastewater
inflow in C1, C2, C3, and C4 were 0.70 ± 0.10, 1.77 ± 0.38,
2.64 ± 0.19, and 0.47 ± 0.04 million gallons per day,
respectively. All samples were collected in one-liter poly-
propylene bottles, transported on ice to the laboratory, stored
at −20 °C, and extracted within 48 h.
Sample Preparation. One hundred milliliters of acidified
(HCl, pH ∼ 2) raw wastewater in duplicates (n = 2) for each
of the four sites were centrifuged at 4500 rpm for 5 min and
filtered under vacuum using 0.45 μm white nylon filter paper
to separate suspended particulate matter. The wastewater
samples were spiked with 50 or 100 ng of internal standards,
mixed well, and extracted using Oasis MCX 6 cc solid-phase
extraction cartridge. Before extraction, cartridges were
conditioned with 3.0 mL of methanol followed by 3.0 mL of
acidified ultrapure water (formic acid, pH ∼ 2). The samples
were extracted at a rate of ∼1 mL/min, dried under vacuum for
∼5 min, eluted with 5.0 mL of 5% ammonia in methanol, and
stored at −20 °C. The eluate was concentrated to ∼250 μL
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under a gentle flow of nitrogen gas at ambient conditions. The
concentrate was transferred quantitatively to an amber
silanized LC vials and the final volume was adjusted to ∼1.0
mL with methanol. One microliter of all prepared samples was
subjected to the instrumental analysis.
Instrumental Analysis. Ultrahigh-performance liquid
chromatography (Agilent 1290 Infinity II LC System) was
coupled with tandem mass spectrometry (Agilent 6460 triple
quadrupole mass spectrometer) (Santa Clara, CA) to analyze
the prepared samples for target drug residues. Target analytes
were chromatographically separated (Figure 1, Supporting
Information (SI) Figure S1) by using a Force Biphenyl column
(100 mm× 2.1 mm i.d. × 1.8 μm particle size) and the gradient
flow of HPLC-grade methanol and 0.1% aqueous solution of
formic acid (SI Table S1). Relative retention time (±0.05 min)
to their deuterated forms, two parent-to-daughter ion
transitions (SI Table S2), and the ratio of the abundance of
quantitative to qualitative ions (±20%) were used for target
analyte peak identification. The collision energy for multiple
reaction monitoring transitions were optimized for all analytes
and internal standards (SI Table S2). The source parameters
including gas temperature (330 °C), gas flow rate (5 L/min),
nebulizer (30 psi), sheath gas temperature (250 °C), sheath
gas flow rate (12 L/min), and capillary voltage (4000 V) were
used.
Analytes were quantified using the isotopic dilution mass
spectrometry method where a known quantity of deuterated
isotopes of drugs was spiked into the sample prior to sample
preparation. This method corrects for the loss of analytes
during the sample preparation and instrumental analysis.
However, closely related deuterated internal standards from
the same class and or adjacent retention times were used for
the quantification of select drugs that were not commercially
available. Valeryl fentanyl-d5 was used as an internal standard
for 2-methyl-4′-(methylthio)-2-morpholinopropiophenone, cy-
clopropyl fentanyl-d5 for 3′-methyl fentanyl, 4-fluoro-isobutyryl
fentanyl-d7 for para-fluorobutyryl fentanyl, 4′-methyl acetyl
fentanyl-d5 for benzyl fentanyl, methoxyacetyl fentanyl-d5 for
Figure 1. Schematic diagram showing the chromatographic separation of select drugs in a drug-spiked (50 or 100 ng) wastewater extract. All other
target drug’s chromatograms are presented in SI Figure S1.
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4-chloro-α-PVP, MAB-CHMINACA-d4 for 5-fluoro MDMB-
PICA, MMB-FUBINACA, 5-fluoro EDMB-PINACA, (R)-5-
fluoro ADB, MMB-CHMICA, AB-CHMINACA, 5-fluoro
AMB, and NM2201, AB-FUBINACA-d4 for ADB-FUBINA-
CA, N-ethylpentylone-d5 for 4-methyl pentedroneand α-
ethylaminohexanophenone, methcathinone-d3 for 5IT, and
Figure 2. Absolute spiking recoveries of target NPSs (n = 3) at (A) 50 or 100 ppb and (B) 2 or 4 ppb using HLB-N (pH ∼ 7 sample using HLB),
HLB-A (pH ∼ 2 sample using HLB), MCX, and WCX cartridges. mCPP: 1-(3-chlorophenyl) piperazine; MMMP: 2-methyl-4′-(methylthio)-2-
morpholinopropiophenone; 5IT: 5-(2-aminopropyl) Indole.
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ethylone-d5 for α-pyrrolidinopropiophenone and 4-methylam-
phetamine. The concentration-dependent response factor was
plotted against the response-dependent concentration factor to
produce a nine-to-12-point calibration curve for each target
drug. The regression coefficients calculated by linear or
quadratic regression were r2 ≥ 0.99 for all target analytes. All
quantitate analysis was performed using Mass Hunter Version
10.0.
Optimization of Extraction Efficiency. Oasis HLB (6 cc,
200 mg), MCX (6 cc, 150 mg), and WCX (6 cc, 150 mg)
solid-phase extraction cartridges and different extraction
eluents were evaluated for the optimum simultaneous
extraction of target drugs. Hydrophilic−lipophilic balance
(HLB) are broad-spectrum cartridges and ideal for acidic,
basic, and neutral analytes. Mixed-mode, strong cation-
exchange (MCX) cartridges are selective for bases with organic
solvents, whereas weak cation-exchange (WCX) cartridges are
mixed-mode and used for strong bases with organic solvents.26
In this study, absolute spiking recoveries (n = 3) were
determined at a lower spiking level (2.0 or 4.0 ng) as well as
midpoint calibration level (50 or 100 ng).
The HLB cartridges were conditioned with 3.0 mL of
methanol followed by 3.0 mL of ultrapure water to extract
nonacidified (pH ∼ 7) filtered wastewater. The extraction
recovery of target drugs from HLB cartridges was also
evaluated in acidic conditions (HLB-A), conditioned using
3.0 mL of methanol followed by 3.0 mL of acidified ultrapure
water (formic acid, pH ∼ 2) and extracted the acidified
wastewater. All HLB cartridges were dried under vacuum for
∼5 min, and eluted with 5.0 mL of 2% ammonia in methanol,
as reported elsewhere.21,24
The MCX cartridges were conditioned with 3.0 mL of
methanol followed by 3.0 mL of acidified ultrapure water
(formic acid, pH ∼ 2), used to extract ∼100 mL of acidified
wastewater, dried under vacuum, and eluted with 5.0 mL of 5%
ammonia in methanol. However, WCX cartridges were
conditioned with 3.0 mL of methanol followed by 3.0 mL of
ultrapure water, extracted nonacidified (pH ∼ 7) wastewater,
dried under vacuum, and eluted with 5% formic acid in
methanol, as described elsewhere.15
All eluates were collected and concentrated as described
above, spiked with 50 or 100 ng of internal standards, and
adjusted to a final volume of ∼1 mL with methanol. The
spiking recovery of drugs was also evaluated at more
environmental relevant concentrations (spiking 2 or 4 ng of
target analytes) similarly as described above. A control sample
spiked with internal standard mixture (but not spiked with the
target drugs) was analyzed at the beginning and the end of the
analysis of sample batch; the average concentrations of drugs
in the blank (if any) were subtracted from the samples. At 2 or
4 ppb spiking level, the absolute spiking recoveries of target
NPSs using MCX and WCX ranged from 51.8 ± 0.34% (4-
methylamphetamine) to 132 ± 3.2% (MAB-CHMINACA)
and 48.0 ± 1.5% (4-methylamphetamine) to 128 ± 0.90%
(cyclopropyl fentanyl), respectively, whereas the absolute
spiking recoveries of target NPSs using HLB and HLB-A
ranged from 50.6 ± 1.5% (4-methylamphetamine) to 115 ±
3.4% (MAB-CHMINACA) and 50.6 ± 4.0% (4-methylam-
phetamine) to 132 ± 2.5% (cyclopropyl fentanyl), respectively
(Figure 2). Overall, the triplicate spiking recoveries of target
NPSs using MCX extraction cartridge found an optimum at
both spiking levels; MCX was considered for the extraction of
NPSs from the collected wastewater samples to determine
their occurrence in communities. More details are provided in
the SI.
Quality Assurance and Quality Control. Along with the
analysis of sample extracts, a method blank and a matrix-spike
sample (n = 2) were incorporated. A method blank consisted
of acidified ultrapure water (pH ∼ 2, HCl) spiked with 50 or
100 ng of internal standards prior to extraction as described
above. A random wastewater sample was considered for
matrix-spike samples, spiked with 50 or 100 ng of target
analytes prior to extraction, and was processed as described
above. As a calibration check standard, a mixture of standards
at the midpoint calibration-level was analyzed after every 10
samples.
The method detection limit (MDL) was defined as the
minimum concentration of an analyte that can be distinguished
from the method blank and can be reported with 99%
confidence.27 MDL was performed according to the U.S.
Environmental Protection Agency’s Code of Federal Regu-
lations.27 Briefly, the wastewater samples (100 mL, n = 7) were
acidified, centrifuged, filtered, and spiked with target drugs (0.1
or 0.2 ng) and internal standards (50 or 100 ng), and
processed as described in Section 2.3. MDL was determined
using the following equation:
tMDL s n 1,1 0.99= × − −∝=
where s is the standard deviations of the measured
concentrations of a drug in seven replicate samples and t is
the Student’s t at 99% confidence level (3.143 for n−1 = 6).
The 95% confidence interval was estimated as
lower confidence limit(LCL) 0.64 MDL= ×
upper confidence limit(UCL) 2.20 MDL= ×
The limits of detection (LODs) and limits of quantification
(LOQs) were defined as the calculated minimum concen-
tration of analytes corresponding to the signal-to-noise ratio 3
and 10, respectively, in wastewater extracts (n = 7) spiked with
standards at the first calibration level (0.1 or 0.2 ng). A check
standard was analyzed nine consecutive times for intraday
repeatability as well as for nine consecutive days for the
interday repeatability.
Mass Load Calculation. The mass load of NPSs was
determined in four rural communities (C1, C2, C3, and C4) in
Southern Illinois based on the residual level of NPSs quantified
in raw wastewater samples during a typical week with no






















zzz= × × ×
where the mass load was expressed as mg/d/1000 people, daily
average wastewater inflow was considered, and the daily
population served by the WWTP was determined based on a
load of ammoniacal nitrogen in raw wastewater. The
ammoniacal nitrogen was measured using a portable DR
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3900 spectrophotometer and Hach Company standard TNT











where CNH4−N is the concentration of ammoniacal nitrogen
(mg/L), Fi is the wastewater inflow (L/d) for the ith day, and
RNH4−N is an average per-capita daily production of
ammoniacal nitrogen (6900 mg/d).6,28 The nonhuman sources
of ammoniacal nitrogen could not be corrected; however, it is
least affected by nonhuman sources compared to other
Table 1. Select Figure of Merits Including the Method Detection Limits (MDLs), Limits of Detection (LODs), Limits of















carfentanil 1.00 0.70−2.30 0.50 1.50 0.71 1.16
furanyl fentanyl 1.50 1.00−3.30 0.90 3.20 0.30 0.76
valeryl fentanyl 1.00 0.70−2.20 0.10 0.20 0.50 0.58
butyryl fentanyl 1.10 0.70−2.50 0.30 0.90 0.68 0.85
acetyl fentanyl 0.70 0.50−1.60 0.10 0.40 0.36 0.92
cyclopropyl fentanyl 0.90 0.60−2.00 0.20 0.70 0.60 0.70
benzyl fentanyl 0.90 0.60−2.00 0.10 0.50 0.65 1.10
3′-methyl fentanyl 1.30 0.80−2.90 0.10 0.30 0.53 0.48
4′-methyl acetyl fentanyl 0.80 0.50−1.70 0.10 0.20 0.73 0.67
4-fluoro-isobutyryl fentanyl 1.30 0.80−2.80 0.10 0.0.20 2.19 0.32
para-fluorobutyryl fentanyl 0.70 0.50−1.60 6.60 22.0 1.14 0.61
methoxyacetyl fentanyl 0.70 0.40−1.50 0.10 0.20 0.58 0.73
4-ANPP 1.30 0.90−3.00 0.40 1.20 0.66 1.22
U-48800 1.20 0.80−2.60 0.10 0.30 0.69 1.10
U-47700 1.00 0.60−2.20 0.30 1.00 0.44 0.67
Synthetic Cannabinoids
5-fluoro MDMB-PICA 1.00 0.60−2.20 0.20 0.70 0.94 2.57
MAB-CHMINACA 1.80 1.10−3.90 6.30 21.0 4.19 3.29
MMB-FUBINACA 2.90 1.90−6.40 0.80 2.60 1.56 2.33
5-fluoro EDMB-PINACA 2.30 1.50−5.10 0.10 0.40 1.98 2.93
(R)-5-fluoro ADB 1.10 0.70−2.40 0.40 1.20 1.60 1.09
AB-FUBINACA 0.90 0.60−1.90 2.20 7.30 2.09 1.62
MMB-CHMICA 0.50 0.30−1.10 0.20 0.60 0.66 1.47
AB-CHMINACA 1.70 1.10−3.80 1.30 4.20 2.04 2.02
ADB-FUBINACA 0.90 0.50−1.90 1.0. 3.50 3.32 1.41
5-fluoro AMB 0.80 0.50−1.70 0.20 0.50 1.05 1.38
NM2201 2.80 1.80−6.20 0.40 1.30 1.37 2.98
Synthetic Cathinones
methcathinone 1.20 0.80−2.70 0.70 2.20 0.97 0.99
ethylone 1.0. 0.70−2.30 0.30 1.00 0.33 0.67
4-MMC (mephedrone) 1.60 1.10−3.60 1.00 3.30 0.78 3.15
4-methyl pentedrone 1.60 1.00−3.60 2.40 7.80 1.73 2.04
N-ethylpentylone 1.70 1.10−3.70 2.30 7.70 0.38 0.81
α-pyrrolidinopropiophenone 1.50 1.00−3.30 0.50 1.50 0.40 1.40
3,4-methylenedioxypyrovalerone 0.90 0.60−2.10 0.40 1.40 0.45 0.76
α-ethylaminohexanophenone 1.40 0.90−3.20 2.50 8.40 0.61 2.53
2-methyl-4′-(methylthio)-2-
morpholinopropiophenone
0.60 0.40−1.30 0.20 0.80 0.40 1.52
4-chloro-α-PVP 1.30 0.90−2.90 0.40 1.30 0.56 1.27
Piperazines
1-(3-chlorophenyl) piperazine (mCPP) 2.20 1.40−4.80 0.90 2.90 1.93 1.80
1-cyclohexyl-4-(1,2-diphenylethyl) piperazine
(MT-45)
0.80 0.50−1.90 0.10 0.30 0.59 0.65
Indole
5-(2-aminopropyl) Indole (5IT) 3.30 2.10−7.20 3.30 10.9 1.32 7.31
Amphetamine
4-methylamphetamine 6.30 4.10−13.9 1.70 5.50 0.67 3.38
Anticonvulsants
clonazepam 3.40 2.20−7.50 1.90 6.30 0.78 1.61
gabapentin 248 159−546 3.40 11.2 1.64 2.45
aRelative standard errors (±).
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conventional water-quality parameters including total nitrogen,
total phosphorus, chemical oxygen demand, and chemical
oxygen demand.28
■ RESULTS AND DISCUSSION
Figure of Merits. The average concentration of target
drugs in method blanks were below the lowest calibration
level; however, methcathinone and gabapentin were measured
at 2.60 and 8.10 ng/L, respectively. All reported concentrations
hereby are blank-corrected. Analytical data points detected <
MDL were substituted with 1/2 MDL values when the
detection frequency is ≥70%.
The average matrix-spiking recoveries (%) of target analytes
in a randomly selected wastewater sample (n = 2) ranged from
46.9% (NM 2201) to 164% (methoxyacetyl fentanyl). The
spiking recovery of gabapentin could not be determined due to
its higher background concentration (>16 folds than the
spiking level) in wastewater. Two (5IT and 3′-methyl fentanyl)
of the 19 target drugs that were quantified using the internal
standard of other analytes resulted in elevated spiking
Table 2. Average Concentration of Quantified NPSs in Raw Wastewater from Four Communities in Southern Illinoisa
analytes C1 (ng/L ± SE) C2 (ng/L ± SE) C3 (ng/L ± SE) C4 (ng/L ± SE)
Synthetic Opioids
carfentanil 1.9 ± 0.1 1.3 ± 0.1 0.5 ± 0.1 0.4 ± 0.2
furanyl fentanyl 1.0 ± 0.3 0.6 ± 0.3 0.6 ± 0.2 ND
methoxyacetyl fentanyl <MDL <MDL ±0.1 2.3 ± 0.5
Synthetic Cannabinoids
MAB-CHMINACA 2.5 ± 0.6 4.0 ± 0.9 4.4 ± 1.0 0.6 ± 0.3
Synthetic Cathinones
methcathinone 11.3 ± 0.8 17.8 ± 1.3 34.3 ± 2.1 16.9 ± 2.6
4-methyl pentedrone 5.3 ± 0.3 0.4 ± 0.3 0.7 ± 0.2 5.8 ± 0.2
MMMP 1.6 ± 0.1 1.3 ± 0.1 0.9 ± 0.1 0.4 ± 0.05
Piperazine
mCPP 56.4 ± 2.7 42.1 ± 2.6 10.3 ± 0.3 2.3 ± 0.6
indole
5IT 4.3 ± 1.5 3.6 ± 1.4 5.3 ± 1.6 19.2 ± 6.3
Anticonvulsant
gabapentin 131,000 ± 7600 58,600 ± 5100 25,500 ± 1150 12,100 ± 1370
aMDL: method detection limit; ND: non detected, MMMP: 2-methyl-4′-(methylthio)-2-morpholinopropiophenone; mCPP: 1-(3-chlorophenyl)
piperazine; 5IT: 5-(2-aminopropyl) indole.
Figure 3. Representative chromatograms of selected drugs quantified in wastewater samples. (A) methcathinone; (B) MAB-CHMINACA; (C)
mCPP [1-(3-chlorophenyl) piperazine]. The top chromatogram corresponds to the quantitative MS/MS transition; middle one corresponds to the
qualitative MS/MS transition; and the bottom one corresponds to the internal standard.
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recoveries (201 and 254%, respectively). The average
percentage recoveries of target drugs from the calibration
check standards that were analyzed along with the sample
extracts ranged from 84.7% (5-IT) to 140% (mCPP); however,
4-methylamphetamine and 2-methyl-4′-(methylthio)-2-mor-
pholinopropiophenone were recovered at 49.6% and 152%,
respectively.
The method detection limit of NPSs determined using seven
replicates of the spiked sample matrix ranged from 0.5 ng/L
(MMB-CHMICA) to 6.3 ng/L (4-methylamphetamine)
(Table 1). LODs ranged from 0.1 ng/L (valeryl fentanyl) to
6.6 ng/L (para-fluorobutyryl fentanyl), whereas LOQs ranged
from 0.2 ng/L (valeryl fentanyl) to 22.0 ng/L (para-
fluorobutyryl fentanyl) (Table 1). The interday precision
expressed as a relative standard error of the measured
concentrations of drugs from the repeated analysis of a
check standard solution for nine consecutive days ranged from
±0.32 (4-fluoro-isobutyryl fentanyl) to ±7.31 (5IT) whereas
the intraday precision for nine consecutive runs ranged from
±0.30 (furanyl fentanyl) to ±4.19 (MAB-CHMINACA)
(Table 1).
Occurrence of NPSs in Wastewater. Nine NPSs were
quantified in all four communities in Southern Illinois (Table
2, Figure 3). Methcathinone was the most frequently detected
NPSs (frequency of detection, df = 100%) in all target
communities followed by 2-methyl-4′-(methylthio)-2-morpho-
linopropiophenone (a synthetic cathinone, df = 91%) and
mCPP (piperazine, df = 91%). Methcathinone was reported as
the most frequently detected NPS in wastewater across
Australia23 and Italy.11 The concentration of methcathinone
in this study was found ∼2−4 folds higher than in Florence
and ∼10−30 folds higher than in Milan, Italy.11 4-methyl
pentedrone (a cathinone) was also detected in all samples from
communities C1 and C4, whereas MAB-CHMINACA (a
cannabinoid) was detected in communities C1, C2, and C3 in
>75% samples. Among synthetic opioids, carfentanil was
detected in all samples from communities C1 and C2.
Methoxyacetyl fentanyl and 5IT (an indole) were detected
>90% samples from community C4. Overall, methcathinone
(11.3−34.3 ng/L) and mCPP (2.3−56.4 ng/L) were more
prevalent in target communities.
Estimation of the Population in WWTP Catchments.
Wastewater based epidemiologists typically report mass
loading of drugs (mg/d/1000 people) to the WWTPs utilizing
de jure population provided by the WWTP operators.
However, de jure population does not account for the
dynamicity in the population of the community.6,28 We
recently reported that the ammoniacal nitrogena biomarker
of the population in the communitycan account for the
dynamicity in the population of the community and provide a
near-accurate estimation of the population over the census
population.6 Baz-Lomda et al.29 also reported that the
population estimated based on ammoniacal nitrogen was
found the best (mean absolute errors <10%) anthropogenic
proxy to determine the population of WWTP catchment area
in Norway among other potential predictors such as drinking
water production and electricity consumption. The ammonia-
cal based population estimation of Oslo was >4% higher than
the “de jure” population.29 In this study, the near-accurate
population in WWTP catchments was determined using a load
of ammoniacal nitrogen in raw wastewater (Table 3).
Mass Loading of NPS. The amount of NPS residues influx
to the WWTP was determined and reported as the mass
loading (mg/d/1000 people) (Figure 4). The mass load of
methcathinone ranged from 2.98 ± 0.17 mg/d/1000 people in
C1 to 21.1 ± 1.31 mg/d/1000 people in C3. Synthetic
synthetic cathinones are among the most consumed NPSs11
and typically consumed as the “pure” form or “adulterants” in
conventional illicit drugs, such as “ecstasy” pills.30 The actual
amount of methcathinone consumed could be higher as
synthetic cathinones undergo extensive metabolism in the
human body15,31 as well as in-sewer transformation including
the reduction of a β-keto group, demethylenation, and
demethylation.32
The mass load of the most prevalent cathinone (methcathi-
none) in community C3 was 3−7 folds higher than in C1 and
C2, whereas the mass load of piperazine (mCPP) was >2 folds
higher in C1 and C2 than in C3. The population is more
diverse in community C3 including ∼50% of college students
than in community C1 and C2. mCPP was prevalent in all
target communities (1.23 ± 0.32 to 15.0 ± 0.5 mg/d/1000
people) in this study. Causanilles et al.21 reported mCPP
qualitatively in wastewater during a street festival in
Amsterdam, Netherland. mCPP was not detected across
China; however, benzylpiperazine was prevalent at 3−10
mg/d/1000 people.22 To our knowledge, this is the first
quantitative report of mCPP in wastewater.
Table 3. Estimated Population of Four Communities in









C1 7882 23.2 ± 1.9 9283 ± 397
C2 17 620 21.1 ± 2.1 19,597 ± 799
C3 20 000c 10.3 ± 0.5 16,253 ± 976
C4 2188 10.8 ± 0.9 2980 ± 239
aCensus annual estimate of the resident population by the U.S.
Census Bureau in 2018. bAverage ± standard error. cWWTP
operator’s estimation.
Figure 4. Average mass loading (mg/d/1000 people) of quantified
NPSs to the WWTPs in four rural communities in Illinois. MMMP: 2-
methyl-4′-(methylthio)-2-morpholinopropiophenone; mCPP: 1-(3-
chlorophenyl) piperazine; 5IT: 5-(2-aminopropyl) Indole.
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5IT (a stimulant, 9.75 ± 2.72 mg/d/1000 people) and 4-
methyl pentedrone (a cathinone, 3.38 ± 0.18 mg/d/1000
people), and methoxyacetyl fentanyl (1.36 ± 0.28 mg/d/1000
people), were more prevalent in community C4. NPSs are also
considered a cheap-substitute of conventional drugs of abuse;
therefore, more prevalent in socially marginalized commun-
ities.10 Community C4 is relatively a socially marginalized
community with >30% residents below the poverty line. The
mass load of MAB-CHMINACA, the only cannabinoid
quantified, was up to 2.59 ± 0.56 mg/d/1000 people in
community C3. To our knowledge, this is the first quantitative
report of MAB-CHMINACA in wastewater. In a nationwide
survey among 45 400 high school senior students, synthetic
cannabinoids were the third most widely abused class of drugs
in the U.S.33 The carfentanil was the only synthetic opioid
quantified in all wastewater samples in community C1 (0.51 ±
0.03 mg/d/1000 people) and C2 (0.41 ± 0.04 mg/d/1000
people). Carfentanil is ∼100 folds more potent than fentanyl.
The occurrence of carfentanil in this study (C1 and C2) was
∼300 folds lower than the occurrence of fentanyl (152 mg/d/
1000 people) in two communities in adjoined state of
Kentucky.6
Unlike established illicit or prescribed drugs of potential
abuse, the pharmacokinetic profiles of most of the NPS’s
excretion are still unknown.11,34 As a result, all quantitative
WBE studies are limited to reporting the mass loading of NPSs
to the WWTPs. The near-accurate estimation of the prevalence
of NPSs would require to normalize mass load with the
excretion rate of target NPSs (or their stable metabolites), the
stability of NPS biomarkers in wastewater, and the typical does
of the NPSs. To our knowledge, no wastewater stability data
are available of target NPSs; however, only one study reported
methcathinone’s human excretion rate of 36% as a parent
drug.35 The excretion rate corrected mass load of methcathi-
none were 8.29 ± 0.46 mg/1000 people, 16.6 ± 2.63 mg/1000
people, 58.6 ± 3.63 mg/1000 people, and 26.1 ± 3.00 mg/
1000 people at the target communities C1, C2, C3, and C4,
respectively. Further study on the pharmacokinetic profiles of
the NPSs execration as well as the stability of NPSs in sewer
networks and the wastewater samples is inevitable to
determine the prevalence of community consumption of NPSs.
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